|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
EP0378881B1
(en)
|
1989-01-17 |
1993-06-09 |
ENIRICERCHE S.p.A. |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
US7252829B1
(en)
*
|
1998-06-17 |
2007-08-07 |
Idm Pharma, Inc. |
HLA binding peptides and their uses
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
WO2001000225A1
(en)
*
|
1999-06-29 |
2001-01-04 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
US5550214A
(en)
|
1994-02-10 |
1996-08-27 |
Brigham And Women's Hospital |
Isolated antigenic oncogene peptide fragments and uses
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
ES2275499T3
(es)
|
1999-03-19 |
2007-06-16 |
Glaxosmithkline Biologicals S.A. |
Vacuna contra streptococcus pneumoniae.
|
|
WO2000061761A2
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
AU2087401A
(en)
*
|
1999-12-10 |
2001-06-18 |
Epimmune, Inc. |
Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
|
|
WO2001058479A1
(en)
|
2000-02-08 |
2001-08-16 |
The Penn State Research Foundation |
Immunotherapy using interleukin 13 receptor subunit alpha 2
|
|
CN1452634A
(zh)
|
2000-02-23 |
2003-10-29 |
埃皮缪纳股份有限公司 |
Hla结合肽及其用途
|
|
US7892559B2
(en)
|
2002-01-30 |
2011-02-22 |
Survac Aps |
Survivin-derived peptides and use thereof
|
|
CA2480008C
(en)
|
2002-03-22 |
2015-10-06 |
The Penn State Research Foundation |
Use of il-13 receptor subunit alpha 2 as an anti-cancer vaccine
|
|
CA2500715A1
(en)
*
|
2002-10-03 |
2004-04-15 |
Epimmune Inc. |
Hla binding peptides and their uses
|
|
CN1954217B
(zh)
*
|
2004-02-06 |
2013-05-08 |
国立健康与医学研究所 |
衍生自gp41的多肽、含有所述多肽的疫苗组合物以及用于治疗个体HIV病毒感染的用途
|
|
WO2006034334A2
(en)
|
2004-09-21 |
2006-03-30 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response
|
|
US7666622B2
(en)
|
2005-10-19 |
2010-02-23 |
Regeneron Pharmaceuticals, Inc. |
Monomeric self-associating fusion polypeptides and therapeutic uses thereof
|
|
WO2008073463A2
(en)
|
2006-12-11 |
2008-06-19 |
Wyeth |
Methods and compositions for treating and monitoring treatment of il-13-associated disorders
|
|
JP2010190572A
(ja)
*
|
2007-06-01 |
2010-09-02 |
Sapporo Medical Univ |
ＩＬ１３Ｒａ２に対する抗体およびこれを含む診断・治療薬
|
|
HRP20131167T1
(hr)
|
2007-06-18 |
2014-01-03 |
Merck Sharp & Dohme B.V. |
Antitijela za humani receptor programirane smrti pd-1
|
|
EP2189471B1
(en)
|
2007-08-20 |
2017-10-04 |
Oncotherapy Science, Inc. |
Foxm1 peptide and medicinal agent comprising the same
|
|
WO2010018136A1
(en)
*
|
2008-08-12 |
2010-02-18 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Minigene comprising htpa signal peptide, t-cell epitopes, e. coli ltb and furin sensitive linkers
|
|
AU2009333580B2
(en)
|
2008-12-09 |
2016-07-07 |
Genentech, Inc. |
Anti-PD-L1 antibodies and their use to enhance T-cell function
|
|
US20110033389A1
(en)
*
|
2009-04-29 |
2011-02-10 |
Zhifeng Chen |
Modified antibodies for passive immunotherapy
|
|
NZ628923A
(en)
|
2009-11-24 |
2016-02-26 |
Medimmune Ltd |
Targeted binding agents against b7-h1
|
|
WO2011140284A2
(en)
|
2010-05-04 |
2011-11-10 |
Fred Hutchinson Cancer Research Center |
Conditional superagonist ctl ligands for the promotion of tumor-specific ctl responses
|
|
EP2608799B1
(en)
|
2010-08-24 |
2018-12-12 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
|
|
EP2639299A1
(en)
|
2012-03-16 |
2013-09-18 |
Invectys |
Universal cancer peptides derived from telomerase
|
|
CA3223380A1
(en)
|
2012-03-19 |
2013-09-26 |
Stemline Therapeutics, Inc. |
Methods for treating and monitoring the status of cancer
|
|
US9428813B2
(en)
|
2012-03-26 |
2016-08-30 |
The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services |
DNA methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
|
|
DK3536334T3
(da)
|
2012-05-16 |
2021-09-13 |
Stemline Therapeutics Inc |
Cancer stamcelle målrettede cancer vacciner
|
|
US20140141044A1
(en)
*
|
2012-11-12 |
2014-05-22 |
Dana-Farber Cancer Institute, Inc. |
Cord Colitis Syndrome Pathogen
|
|
JP6345688B2
(ja)
|
2012-12-05 |
2018-06-20 |
ソラ・バイオサイエンシズ・エルエルシー |
タンパク質発現増強ポリペプチド
|
|
CA2893918C
(en)
|
2012-12-06 |
2020-11-24 |
Callaghan Innovation Research Limited |
Conjugate compounds
|
|
KR20160016725A
(ko)
*
|
2014-08-05 |
2016-02-15 |
주식회사 유영제약 |
암 세포에 과발현되는 IL13Rα2에 특이적으로 결합하는 키메라 항원 수용체로 변형된 T 세포
|
|
EP3259284B1
(en)
|
2015-02-16 |
2020-04-01 |
The Trustees of the University of Pennsylvania |
A fully-human t cell receptor specific for the 369-377 epitope derived from the her2/neu (erbb2) receptor protein
|
|
US20180133327A1
(en)
|
2015-03-16 |
2018-05-17 |
Amal Therapeutics Sa |
Cell Penetrating Peptides and Complexes Comprising the Same
|
|
EP3277800A4
(en)
*
|
2015-03-31 |
2018-11-14 |
Agency For Science, Technology And Research |
Method for antigen loading of dendritic cells and vaccine
|
|
WO2017203526A1
(en)
|
2016-05-23 |
2017-11-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing cancer using cancer testis antigens
|
|
KR102622188B1
(ko)
|
2016-10-07 |
2024-01-05 |
엔터롬 에스.에이. |
암 치료를 위한 면역원성 화합물
|
|
WO2018065628A2
(en)
|
2016-10-07 |
2018-04-12 |
Enterome |
Microbiota sequence variants of tumor-related antigenic epitopes
|
|
US11478538B2
(en)
|
2016-10-07 |
2022-10-25 |
Enterome S.A. |
Immunogenic compounds for cancer therapy
|
|
WO2019072871A2
(en)
|
2017-10-09 |
2019-04-18 |
Enterome S.A. |
MICROBIOTIC SEQUENCE VARIANTS OF ANTIGENIC EPITOPES ASSOCIATED WITH A TUMOR
|
|
CN112118863B
(zh)
|
2018-04-11 |
2025-05-30 |
恩特罗姆公司 |
用于预防和治疗癌症的抗原肽
|
|
EP3773673A2
(en)
|
2018-04-11 |
2021-02-17 |
Enterome S.A. |
Immunogenic compounds for treatment of fibrosis, autoimmune diseases and inflammation
|
|
WO2021074389A1
(en)
|
2019-10-16 |
2021-04-22 |
Enterome S.A. |
Immunogenic compounds for treatment of adrenal cancer
|
|
ES2971929T3
(es)
|
2019-11-15 |
2024-06-10 |
Enterome S A |
Péptidos antigénicos para la prevención y el tratamiento de la neoplasia maligna de linfocitos B
|